Organization named in the records

Oxford Immunotech

Named in 1 passage across 1 document.

Mentions of Oxford Immunotech in the public Epstein records, with citations.

Ask the documents about Oxford Immunotech Search every mention

--}}

Being named in these documents is not an accusation or evidence of wrongdoing. This page reflects only what the public records literally contain, with citations to the original sources.

Where Oxford Immunotech appears

1 total

ER 257 - CONFIDENTIAL James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found New Leaf in 2005. Jim will change his status to Venture Partner in NLV-III with the closing of the new fund. In this role, Jim...

Times Square Tower TEXT-001-HOUSE_OVERSIGHT_024003.txt p.1 View source release ↗

Also named alongside

New York New Leaf NEW LEAF VENTURES III, L.P Harvard Medical School U.S. Securities and Exchange Commission NEW LEAF VENTURE PARTNERS, L.L.C Boston Consulting Group New Leaf Ventures I, L.P All Sprout Funds U.S. Congress New Leaf Venture Partners Philippe Chambon

Want context across all of these passages at once?

Ask the documents about Oxford Immunotech